Disclosed trading activity and conflict signals for members serving on the House Health. Use this surface to see which members trade most often, which issuers recur, and where oversight exposure is concentrated.
National Plan for Epilepsy Act This bill requires the Department of Health and Human Services (HHS) to establish a national plan, form an advisory council, and take other actions to address epilepsy. The requirements sunset on December 31, 2035. Specifically, the bill requires HHS to carry out a National Plan for Epilepsy to prevent, diagnose, treat, and cure epilepsy. In carrying out the plan, HHS must implement activities such as coordinating research and services across all federal agencies and soliciting public comments. Also, HHS must establish an Advisory Council on Epilepsy Research, Care, and Services. The advisory council must report to HHS and Congress every two years with an evaluation of federally funded efforts. Additionally, HHS must annually report to Congress with recommended actions based on its assessments of the nation’s progress on epilepsy.
Held at the desk.
Motion to proceed to consideration of measure rejected in Senate by Yea-Nay Vote. 47 - 52. Record Vote Number: 215.
Rural Obstetrics Readiness Act This bill creates and expands federal grant programs within the Health Resources and Services Administration (HRSA) to increase capacity to provide emergency obstetric health services in rural areas or areas without practitioners or facilities specializing in obstetric services. Specifically, HRSA must establish a program for providing grants to certain hospitals or consortiums that include hospitals in rural areas or areas with maternal health care professional shortages for training, developing a workforce, and purchasing equipment relating to obstetric emergencies. In addition, the bill requires HRSA’s Alliance for Innovation on Maternal Health Capacity program to provide grants for training on emergency obstetric services for practitioners in rural health care facilities without dedicated obstetric units. HRSA must also establish a pilot program to provide grants to government entities for developing or improving telehealth access programs to support urgent maternal health care in rural facilities without a dedicated obstetric unit.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 525.
Motion to proceed to consideration of measure rejected in Senate by Yea-Nay Vote. 45 - 52. Record Vote Number: 190. (CR S3193)
Dental Care for Veterans Act This bill expands eligibility for veterans for dental care provided by the Department of Veterans Affairs (VA). Specifically, the bill makes all veterans who are enrolled in the VA health care system eligible for VA-provided dental services. Currently, only veterans who have a service-connected dental issue or meet other narrow criteria are eligible for certain dental services. The bill phases in eligibility over four years based upon existing eligibility, degree of service-connected disability or other disability, prisoner of war status, award of a Purple Heart, financial need, or VA health care eligibility.
Committee Hearings Held
Protect Infant Formula from Contamination Act This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.
Held at the desk.
Improving Care in Rural America Reauthorization Act of 2025 This bill reauthorizes through FY2030 grant programs administered by the Health Resources and Services Administration (HRSA) that provide funding to health care service providers and related entities in rural areas. Specifically, the bill reauthorizes grants for expanding the delivery of health care services in rural areas, developing integrated health care networks (i.e., collaborative groups of local health care organizations) in rural areas, and improving the quality of services provided by small health care providers in rural areas. Also, the bill requires HRSA to ensure that grant funds for expanding services or developing health care networks are used to (1) meet the health care needs of underserved populations, and (2) engage such populations in the planning and implementation of related activities.
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 377.
Representing our Seniors at VA Act of 2025 This bill expands the membership of the Geriatrics and Gerontology Advisory Committee within the Veterans Health Administration by requiring the addition of one representative from the National Association of State Veterans Homes who holds a professional license in nursing home administration. Additionally, the committee must consult with the National Association of Veterans State Homes with respect to matters concerning the association.
Placed on the Union Calendar, Calendar No. 498.
| Member | Party | State | Role | Trades | Conflicted | Avg Conflict |
|---|---|---|---|---|---|---|
| Lori Trahan | D | MA | Member | 10 | -- | 43.0% |
| Lizzie Fletcher | D | TX | Member | 11 | 5 | 33.0% |
| Greg Landsman |
| Date | Member | Ticker | Type | Amount | Conflict |
|---|---|---|---|---|---|
| Aug 24, 2026 | Michael A. Rulli | GOOGL | Sell | $50,001 - $100,000 | 10% |
| Aug 12, 2026 | Michael A. Rulli | ALL | Sell | $1,001 - $15,000 | 0% |
| D |
| OH |
| Member |
| 178 |
| 25 |
| 32.0% |
| Debbie Dingell | D | MI | Member | 42 | 7 | 26.0% |
| Thomas H. Kean, Jr. | R | NJ | Member | 201 | 31 | 24.0% |
| Cliff Bentz | R | OR | Member | 6 | -- | 16.0% |
| John James | R | MI | Member | 500 | -- | 12.0% |
| Dan Crenshaw | R | TX | Member | 9 | -- | 6.0% |
| Neal P. Dunn | R | FL | Member | 41 | -- | 3.0% |
| Nanette Diaz Barragán | D | CA | Member | 5 | -- | 2.0% |
| Jake Auchincloss | D | MA | Member | 15 | -- | 2.0% |
| Earl L. "Buddy" Carter | R | GA | Member | 16 | -- | 2.0% |
| Michael A. Rulli | R | OH | Member | 35 | -- | 0.0% |
| John Joyce | R | PA | Member | 0 | -- | 0.0% |
| Kat Cammack | R | FL | Member | 0 | -- | 0.0% |
| Troy A. Carter | D | LA | Member | 0 | -- | 0.0% |
| Marc A. Veasey | D | TX | Member | 0 | -- | 0.0% |
| Troy Balderson | R | OH | Member | 0 | -- | 0.0% |
| H. Morgan Griffith | R | VA | Chair | 0 | -- | 0.0% |
| Erin Houchin | R | IN | Member | 0 | -- | 0.0% |
| Robin L. Kelly | D | IL | Member | 0 | -- | 0.0% |
| Mariannette Miller-Meeks | R | IA | Member | 0 | -- | 0.0% |
| Nicholas A. Langworthy | R | NY | Member | 0 | -- | 0.0% |
| Diana DeGette | D | CO | Ranking Member | 0 | -- | 0.0% |
| Alexandria Ocasio-Cortez | D | NY | Member | 0 | -- | 0.0% |
| Diana Harshbarger | R | TN | Member | 0 | -- | 0.0% |
| Kim Schrier | D | WA | Member | 0 | -- | 0.0% |
| Gus M. Bilirakis | R | FL | Member | 0 | -- | 0.0% |
| Jay Obernolte | R | CA | Member | 0 | -- | 0.0% |
| Raul Ruiz | D | CA | Ranking Member | 0 | -- | 0.0% |
| Aug 7, 2026 | Michael A. Rulli | EQIX | Buy | $1,001 - $15,000 | 0% |
| Aug 6, 2026 | Michael A. Rulli | CCI | Sell | $1,001 - $15,000 | 0% |
| Jul 22, 2026 | Thomas H. Kean, Jr. | GOOGL | Sell | $1,001 - $15,000 | 0% |
| Jul 22, 2026 | Thomas H. Kean, Jr. | SYK | Sell | $1,001 - $15,000 | 0% |
| Jul 14, 2026 | Debbie Dingell | -- | Buy | $15,001 - $50,000 | 1% |
| Jul 8, 2026 | Thomas H. Kean, Jr. | AMZN | Buy | $1,001 - $15,000 | 0% |
| Jul 8, 2026 | Thomas H. Kean, Jr. | TOST | Buy | $1,001 - $15,000 | 0% |
| Jul 7, 2026 | Thomas H. Kean, Jr. | ESAB | Buy | $1,001 - $15,000 | 0% |
| Jul 7, 2026 | Thomas H. Kean, Jr. | EQT | Buy | $1,001 - $15,000 | 0% |
| Jul 1, 2026 | Michael A. Rulli | LLY | Sell | $1,001 - $15,000 | 0% |
| Jul 1, 2026 | Michael A. Rulli | KLAC | Buy | $1,001 - $15,000 | 0% |
| Jun 30, 2026 | Thomas H. Kean, Jr. | ADI | Sell | $1,001 - $15,000 | 0% |
| Jun 29, 2026 | Debbie Dingell | HONAV | Sell | $50,001 - $100,000 | 8% |
| Jun 29, 2026 | Debbie Dingell | HONAV | Sell | $15,001 - $50,000 | 1% |
| Jun 29, 2026 | Thomas H. Kean, Jr. | JNJ | Sell | $1,001 - $15,000 | 0% |
| Jun 29, 2026 | Michael A. Rulli | GOOGL | Buy | $1,001 - $15,000 | 0% |
| Jun 29, 2026 | Thomas H. Kean, Jr. | SPGI | Sell | $1,001 - $15,000 | 0% |
| Jun 29, 2026 | Thomas H. Kean, Jr. | MKL | Sell | $1,001 - $15,000 | 0% |
| Jun 25, 2026 | Michael A. Rulli | AMZN | Sell | $1,001 - $15,000 | 0% |
| Jun 25, 2026 | Michael A. Rulli | GOOGL | Buy | $1,001 - $15,000 | 0% |
| Jun 25, 2026 | Michael A. Rulli | MSFT | Sell | $1,001 - $15,000 | 0% |
| Jun 25, 2026 | Michael A. Rulli | NVDA | Buy | $1,001 - $15,000 | 0% |
| Jun 25, 2026 | Michael A. Rulli | AAPL | Sell | $1,001 - $15,000 | 0% |
| Jun 25, 2026 | Michael A. Rulli | MU | Buy | $1,001 - $15,000 | 0% |
| Jun 24, 2026 | Thomas H. Kean, Jr. | GOOGL | Sell | $15,001 - $50,000 | 3% |
| Jun 24, 2026 | Thomas H. Kean, Jr. | ESAB | Buy | $1,001 - $15,000 | 0% |
| Jun 22, 2026 | Thomas H. Kean, Jr. | ESAB | Buy | $1,001 - $15,000 | 0% |
| Jun 17, 2026 | Thomas H. Kean, Jr. | GIL | Sell | $1,001 - $15,000 | 0% |
| Jun 17, 2026 | Thomas H. Kean, Jr. | -- | Buy | $15,001 - $50,000 | 3% |
| Jun 12, 2026 | John James | SPCX | Buy | $15,001 - $50,000 | 1% |
| Jun 4, 2026 | Thomas H. Kean, Jr. | WPM | Buy | $1,001 - $15,000 | 0% |
| Jun 2, 2026 | Thomas H. Kean, Jr. | MKL | Sell | $1,001 - $15,000 | 0% |
| Jun 2, 2026 | Thomas H. Kean, Jr. | MSFT | Sell | $1,001 - $15,000 | 0% |
| Jun 2, 2026 | Thomas H. Kean, Jr. | GOOGL | Sell | $1,001 - $15,000 | 0% |
| Jun 2, 2026 | Thomas H. Kean, Jr. | GIL | Buy | $1,001 - $15,000 | 0% |
| Jun 2, 2026 | Thomas H. Kean, Jr. | JNJ | Sell | $1,001 - $15,000 | 0% |
| Jun 2, 2026 | Thomas H. Kean, Jr. | SYK | Sell | $1,001 - $15,000 | 0% |
| Jun 1, 2026 | Dan Crenshaw | AAPL | Sell | $1,001 - $15,000 | 30% |
| Jun 1, 2026 | Thomas H. Kean, Jr. | EQT | Buy | $1,001 - $15,000 | 0% |
| Jun 1, 2026 | Dan Crenshaw | META | Sell | $1,001 - $15,000 | 0% |
| Jun 1, 2026 | Dan Crenshaw | AMZN | Sell | $1,001 - $15,000 | 0% |
| Jun 1, 2026 | Dan Crenshaw | -- | Sell | $1,001 - $15,000 | 0% |
| Jun 1, 2026 | Dan Crenshaw | GOOG | Sell | $1,001 - $15,000 | 24% |
| Jun 1, 2026 | Thomas H. Kean, Jr. | CHKP | Sell | $1,001 - $15,000 | 0% |
| Jun 1, 2026 | Dan Crenshaw | USOU | Buy | $1,001 - $15,000 | 0% |
| Jun 1, 2026 | Thomas H. Kean, Jr. | CHKP | Sell | $1,001 - $15,000 | 0% |
| Jun 1, 2026 | Thomas H. Kean, Jr. | EQT | Buy | $1,001 - $15,000 | 0% |
| May 26, 2026 | Debbie Dingell | -- | Buy | $50,001 - $100,000 | 10% |
| May 21, 2026 | Thomas H. Kean, Jr. | BDX | Sell | $1,001 - $15,000 | 0% |
| May 18, 2026 | Jake Auchincloss | STT | Sell | $15,001 - $50,000 | 3% |
| May 14, 2026 | Thomas H. Kean, Jr. | AMCR | Buy | $1,001 - $15,000 | 0% |
| May 11, 2026 | Neal P. Dunn | -- | Sell | $15,001 - $50,000 | 0% |
| May 11, 2026 | Neal P. Dunn | -- | Sell | $50,001 - $100,000 | 5% |
| May 11, 2026 | Neal P. Dunn | -- | Sell | $50,001 - $100,000 | 5% |
| May 7, 2026 | Earl L. "Buddy" Carter | -- | Sell | $1,000,001 - $5,000,000 | 7% |
| May 6, 2026 | Michael A. Rulli | META | Buy | $1,001 - $15,000 | 0% |
| May 6, 2026 | Michael A. Rulli | PLTR | Sell | $1,001 - $15,000 | 0% |
| May 5, 2026 | Dan Crenshaw | META | Sell | $1,001 - $15,000 | 0% |
| May 4, 2026 | Thomas H. Kean, Jr. | -- | Buy | $50,001 - $100,000 | 9% |
| Apr 29, 2026 | Thomas H. Kean, Jr. | ADI | Sell | $1,001 - $15,000 | 0% |
| Apr 28, 2026 | Dan Crenshaw | META | Buy | $1,001 - $15,000 | 0% |
| Apr 21, 2026 | Debbie Dingell | -- | Buy | $15,001 - $50,000 | 37% |
| Apr 21, 2026 | Thomas H. Kean, Jr. | TTWO | Sell | $1,001 - $15,000 | 0% |
| Apr 21, 2026 | Debbie Dingell | PTA | Buy | $1,001 - $15,000 | 39% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $100,001 - $250,000 | 43% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $250,001 - $500,000 | 43% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $100,001 - $250,000 | 43% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $250,001 - $500,000 | 43% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $100,001 - $250,000 | 43% |
| Apr 15, 2026 | Thomas H. Kean, Jr. | NVT | Sell | $1,001 - $15,000 | 0% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $100,001 - $250,000 | 43% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $250,001 - $500,000 | 43% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $250,001 - $500,000 | 43% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $100,001 - $250,000 | 43% |
| Apr 15, 2026 | Lori Trahan | -- | Buy | $250,001 - $500,000 | 43% |
| Apr 14, 2026 | Thomas H. Kean, Jr. | TXN | Buy | $1,001 - $15,000 | 0% |
| Apr 14, 2026 | Thomas H. Kean, Jr. | FCNCA | Sell | $1,001 - $15,000 | 0% |
| Apr 9, 2026 | Cliff Bentz | INTC | Sell | $1,001 - $15,000 | 24% |
| Apr 8, 2026 | Lizzie Fletcher | NVDA | Sell | $1,001 - $15,000 | 55% |
| Apr 8, 2026 | Lizzie Fletcher | MSFT | Sell | $1,001 - $15,000 | 55% |
| Apr 8, 2026 | Lizzie Fletcher | KLAC | Sell | $1,001 - $15,000 | 15% |
| Apr 8, 2026 | Lizzie Fletcher | MCK | Sell | $1,001 - $15,000 | 15% |
| Apr 8, 2026 | Lizzie Fletcher | ETN | Sell | $1,001 - $15,000 | 15% |
| Apr 8, 2026 | Lizzie Fletcher | AMP | Sell | $1,001 - $15,000 | 15% |
| Apr 8, 2026 | Lizzie Fletcher | AAPL | Sell | $1,001 - $15,000 | 55% |
| Apr 8, 2026 | Lizzie Fletcher | GOOGL | Sell | $1,001 - $15,000 | 55% |
| Apr 8, 2026 | Lizzie Fletcher | LLY | Sell | $1,001 - $15,000 | 55% |
| Apr 8, 2026 | Lizzie Fletcher | JPM | Sell | $1,001 - $15,000 | 15% |
| Apr 8, 2026 | Lizzie Fletcher | PWR | Sell | $1,001 - $15,000 | 15% |
| Mar 31, 2026 | Thomas H. Kean, Jr. | AMCR | Buy | $1,001 - $15,000 | 23% |
| Mar 26, 2026 | Thomas H. Kean, Jr. | SPGI | Sell | $15,001 - $50,000 | 44% |
| Mar 26, 2026 | Thomas H. Kean, Jr. | CB | Sell | $15,001 - $50,000 | 44% |
| Mar 26, 2026 | Thomas H. Kean, Jr. | JNJ | Sell | $1,001 - $15,000 | 78% |
| Mar 26, 2026 | Thomas H. Kean, Jr. | PEP | Sell | $15,001 - $50,000 | 84% |
| Mar 26, 2026 | Thomas H. Kean, Jr. | LIN | Buy | $1,001 - $15,000 | 38% |
| Mar 26, 2026 | Thomas H. Kean, Jr. | FCNCA | Sell | $1,001 - $15,000 | 38% |
| Mar 10, 2026 | Thomas H. Kean, Jr. | WAT | Sell | $1,001 - $15,000 | 20% |
| Feb 20, 2026 | Michael A. Rulli | MSFT | Sell | $1,001 - $15,000 | 0% |